Exarta Therapeutics
Pre-clinical drug development for cancer tumors.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
* | N/A | - | |
| Total Funding | 000k | ||
Exarta Therapeutics is a pre-clinical biotechnology company founded in 2021 and headquartered in New York, NY. The company operates in stealth mode, focusing on the development of drugs to treat cancer tumors.
As a private, venture capital-backed entity, Exarta Therapeutics is in the early stages of its journey within the life sciences and oncology sectors. The firm's primary industry is biotechnology, with a specific focus on drug discovery. While details about its specific technology or drug candidates are not public due to its stealth operations, the company's objective is to address the oncology market.
The company has received investment from 3E Bioventures Capital. It is situated in New York City, which serves as a hub for its research and development activities.
Keywords: pre-clinical, biotechnology, drug discovery, cancer therapy, oncology, life sciences, stealth mode, cancer tumors, therapeutics, venture capital-backed, biopharmaceutical